BioNTech SE (BNTX) Free Cash Flow (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Free Cash Flow data on file, last reported at $433.8 million in Q4 2025.

• For the quarter ending Q4 2025, Free Cash Flow rose 202.34% year-over-year to $433.8 million; the trailing twelve-month figure through Dec 2025 stood at $815.2 million (up 56.49% YoY), and the FY2025 full-year result was $713.0 million, up 35.02% from the prior year.
• Free Cash Flow retreated to $433.8 million in Q4 2025, from $954.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $4.9 billion in Q3 2022 to a low of -$769.8 million in Q1 2025.
• A 5-year average of $1.2 billion and a median of $687.4 million in 2023 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow jumped 1144001575.84% in 2022 and sank 173.79% in 2025, its largest moves.
• Tracing BNTX's Free Cash Flow over 5 years: stood at $273.3 million in 2021, then soared by 260.55% to $985.4 million in 2022, then climbed by 2.06% to $1.0 billion in 2023, then sank by 142.15% to -$423.9 million in 2024, then jumped by 202.34% to $433.8 million in 2025.
• Business Quant data shows BNTX's Free Cash Flow at $433.8 million in Q4 2025, $954.7 million in Q3 2025, and $196.5 million in Q2 2025.